SIMILAR PATTERNS OF AMINO ACIDS FOR 6IBL_A_H98A501_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bey | CAMPATH-1H ANTIBODY (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 5 | THR H 89VAL H 119VAL H 117VAL H 70TYR H 96 | None | 1.27A | 6iblA-1beyH:undetectable | 6iblA-1beyH:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bvl | HULYS11 (Homo sapiens;Mus musculus) |
PF07686(V-set) | 5 | THR A 86VAL A 114VAL A 112VAL A 67TYR A 93 | None | 1.47A | 6iblA-1bvlA:undetectable | 6iblA-1bvlA:15.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1czi | CHYMOSIN (Bos taurus) |
PF00026(Asp) | 5 | THR E 257VAL E 259VAL E 197PHE E 305VAL E 304 | None | 1.29A | 6iblA-1cziE:undetectable | 6iblA-1cziE:21.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fwx | NITROUS OXIDEREDUCTASE (Paracoccusdenitrificans) |
PF13473(Cupredoxin_1) | 5 | VAL A 283VAL A 291ASP A 193TRP A 347PHE A 328 | None | 1.28A | 6iblA-1fwxA:undetectable | 6iblA-1fwxA:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1m5q | SMALL NUCLEARRIBONUCLEOPROTEINHOMOLOG (Pyrobaculumaerophilum) |
no annotation | 5 | VAL A 119VAL A 112ASP A 81PHE A 85PHE A 93 | None | 1.42A | 6iblA-1m5qA:undetectable | 6iblA-1m5qA:15.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1smk | MALATEDEHYDROGENASE,GLYOXYSOMAL (Citrulluslanatus) |
PF00056(Ldh_1_N)PF02866(Ldh_1_C) | 5 | THR A 199VAL A 204ASP A 193PHE A 238TYR A 245 | None | 1.48A | 6iblA-1smkA:undetectable | 6iblA-1smkA:25.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vbj | PROSTAGLANDIN FSYNTHASE (Trypanosomabrucei) |
PF00248(Aldo_ket_red) | 5 | THR A 75VAL A 104VAL A 133PHE A 124VAL A 138 | None | 1.36A | 6iblA-1vbjA:undetectable | 6iblA-1vbjA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xhb | POLYPEPTIDEN-ACETYLGALACTOSAMINYLTRANSFERASE 1 (Mus musculus) |
PF00535(Glycos_transf_2)PF00652(Ricin_B_lectin) | 5 | VAL A 391VAL A 388ASP A 395ASN A 365TYR A 382 | None | 1.25A | 6iblA-1xhbA:undetectable | 6iblA-1xhbA:22.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xhb | POLYPEPTIDEN-ACETYLGALACTOSAMINYLTRANSFERASE 1 (Mus musculus) |
PF00535(Glycos_transf_2)PF00652(Ricin_B_lectin) | 5 | VAL A 391VAL A 388ASP A 395ASN A 365VAL A 372 | None | 1.41A | 6iblA-1xhbA:undetectable | 6iblA-1xhbA:22.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fp3 | CASPASE NC (Drosophilamelanogaster) |
PF00656(Peptidase_C14) | 5 | VAL A 265VAL A 267ASP A 405PHE A 443PHE A 393 | None | 1.46A | 6iblA-2fp3A:undetectable | 6iblA-2fp3A:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hz2 | CYANOGLOBIN (Synechocystissp. PCC 6803) |
PF01152(Bac_globin) | 5 | THR A 94VAL A 108ASP A 19PHE A 21VAL A 14 | None | 1.44A | 6iblA-2hz2A:undetectable | 6iblA-2hz2A:15.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qny | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 3 (Mycobacteriumtuberculosis) |
PF08541(ACP_syn_III_C)PF08545(ACP_syn_III) | 5 | VAL A 8VAL A 164ASP A 239PHE A 115VAL A 314 | None | 1.29A | 6iblA-2qnyA:undetectable | 6iblA-2qnyA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rag | DIPEPTIDASE (Caulobactervibrioides) |
PF01244(Peptidase_M19) | 5 | VAL A 401VAL A 405ASP A 360PHE A 155VAL A 96 | NoneNone CL A 420 ( 4.1A)NoneNone | 1.42A | 6iblA-2ragA:undetectable | 6iblA-2ragA:22.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y3a | PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT BETA ISOFORM (Mus musculus) |
PF00454(PI3_PI4_kinase)PF00613(PI3Ka)PF00792(PI3K_C2)PF00794(PI3K_rbd)PF02192(PI3K_p85B) | 5 | THR A 475VAL A 473PHE A 442PHE A 645VAL A 139 | None | 1.44A | 6iblA-2y3aA:undetectable | 6iblA-2y3aA:17.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zbv | UNCHARACTERIZEDCONSERVED PROTEIN (Thermotogamaritima) |
PF01887(SAM_adeno_trans) | 5 | THR A 6VAL A 65VAL A 89ASN A 93VAL A 71 | NoneNoneNoneNoneADN A 501 ( 4.5A) | 1.46A | 6iblA-2zbvA:undetectable | 6iblA-2zbvA:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zkj | [PYRUVATEDEHYDROGENASE[LIPOAMIDE]] KINASEISOZYME 4 (Homo sapiens) |
PF02518(HATPase_c)PF10436(BCDHK_Adom3) | 5 | THR A 82VAL A 85VAL A 88ASP A 143PHE A 162 | None | 1.21A | 6iblA-2zkjA:2.1 | 6iblA-2zkjA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b9t | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Methylobacillusflagellatus) |
PF03069(FmdA_AmdA) | 5 | ASP A 341PHE A 290PHE A 337PHE A 366TYR A 328 | MG A 484 (-2.0A)NoneNoneNoneNone | 1.49A | 6iblA-3b9tA:undetectable | 6iblA-3b9tA:22.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d3l | ARACHIDONATE12-LIPOXYGENASE,12S-TYPE (Homo sapiens) |
PF00305(Lipoxygenase) | 5 | VAL A 367ASP A 512PHE A 515PHE A 528VAL A 517 | None | 1.28A | 6iblA-3d3lA:undetectable | 6iblA-3d3lA:22.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f9r | PHOSPHOMANNOMUTASE (Trypanosomabrucei) |
PF03332(PMM) | 5 | THR A 235VAL A 239ASP A 10PHE A 9PHE A 38 | None | 1.32A | 6iblA-3f9rA:undetectable | 6iblA-3f9rA:19.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ibz | PUTATIVE TELLURIUMRESISTANT LIKEPROTEIN TERD (Streptomycescoelicolor) |
PF02342(TerD) | 5 | VAL A 191VAL A 189ASP A 113PHE A 62ASN A 64 | None | 1.47A | 6iblA-3ibzA:undetectable | 6iblA-3ibzA:16.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | TRP A 453THR A 537VAL A 541VAL A 544ASP A 472 | NoneNoneNoneNoneTRS A6001 (-3.2A) | 1.19A | 6iblA-3lppA:undetectable | 6iblA-3lppA:17.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pbl | D(3) DOPAMINERECEPTOR, LYSOZYMECHIMERA (Homo sapiens;Escherichiavirus T4) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 5 | VAL A 111TRP A 342PHE A 345PHE A 346TYR A 373 | ETQ A1200 (-3.4A)NoneETQ A1200 (-4.4A)ETQ A1200 ( 4.5A)ETQ A1200 (-4.4A) | 0.51A | 6iblA-3pblA:28.8 | 6iblA-3pblA:27.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pds | FUSION PROTEINBETA-2 ADRENERGICRECEPTOR/LYSOZYME (Homo sapiens;Escherichiavirus T4) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 10 | TRP A 109THR A 110VAL A 114VAL A 117ASP A 192PHE A 193TRP A 286PHE A 289PHE A 290TYR A 316 | NoneERC A1201 ( 4.6A)ERC A1201 (-3.8A)NoneERC A1201 (-4.2A)ERC A1201 (-4.4A)NoneERC A1201 (-4.5A)ERC A1201 (-4.8A)None | 0.84A | 6iblA-3pdsA:32.2 | 6iblA-3pdsA:37.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pds | FUSION PROTEINBETA-2 ADRENERGICRECEPTOR/LYSOZYME (Homo sapiens;Escherichiavirus T4) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 10 | TRP A 109THR A 110VAL A 114VAL A 117ASP A 192TRP A 286PHE A 289PHE A 290ASN A 293TYR A 316 | NoneERC A1201 ( 4.6A)ERC A1201 (-3.8A)NoneERC A1201 (-4.2A)NoneERC A1201 (-4.5A)ERC A1201 (-4.8A)ERC A1201 (-3.5A)None | 0.77A | 6iblA-3pdsA:32.2 | 6iblA-3pdsA:37.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3py6 | BETA-LACTAMASE-LIKE (Brucellaabortus) |
PF12706(Lactamase_B_2) | 5 | THR A 63VAL A 60VAL A 59ASP A 96VAL A 102 | None | 1.48A | 6iblA-3py6A:undetectable | 6iblA-3py6A:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rkr | SHORT CHAINOXIDOREDUCTASE (unculturedbacterium Bio5) |
PF00106(adh_short) | 5 | THR A 36VAL A 10VAL A 88ASP A 63VAL A 114 | NoneNoneNoneNAP A 240 (-3.8A)None | 1.27A | 6iblA-3rkrA:undetectable | 6iblA-3rkrA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3woz | CLIP-ASSOCIATINGPROTEIN 2 (Mus musculus) |
no annotation | 5 | THR A 810VAL A 814VAL A 817ASP A 803PHE A 804 | None | 0.79A | 6iblA-3wozA:undetectable | 6iblA-3wozA:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4aoy | ISOCITRATEDEHYDROGENASE [NADP] (Ruminiclostridiumthermocellum) |
PF00180(Iso_dh) | 5 | THR A 363VAL A 114ASP A 389PHE A 390ASN A 325 | None | 1.28A | 6iblA-4aoyA:undetectable | 6iblA-4aoyA:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4etq | ANTI-VACCINIA D8LANTIGEN MURINEMONOCLONAL IGG2AANTIBODY LA5, HEAVYCHAIN (Mus musculus) |
no annotation | 5 | THR H 88VAL H 118VAL H 116ASP H 67TYR H 95 | None | 1.38A | 6iblA-4etqH:undetectable | 6iblA-4etqH:18.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f0q | RESTRICTIONENDONUCLEASE (Mycobacteriumsp. JLS) |
PF04471(Mrr_cat) | 5 | THR A 388VAL A 386ASP A 294PHE A 300PHE A 335 | None | 1.40A | 6iblA-4f0qA:undetectable | 6iblA-4f0qA:21.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4gbr | BETA-2 ADRENERGICRECEPTOR (Homo sapiens) |
PF00001(7tm_1) | 10 | TRP A 109THR A 110VAL A 114VAL A 117ASP A 192PHE A 193TRP A 258PHE A 261PHE A 262TYR A 288 | NoneCAU A 500 ( 4.0A)CAU A 500 (-3.5A)CAU A 500 (-4.2A)NoneCAU A 500 (-4.5A)NoneCAU A 500 (-4.2A)CAU A 500 (-4.6A)CAU A 500 (-4.6A) | 0.72A | 6iblA-4gbrA:32.4 | 6iblA-4gbrA:50.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4gbr | BETA-2 ADRENERGICRECEPTOR (Homo sapiens) |
PF00001(7tm_1) | 10 | TRP A 109THR A 110VAL A 114VAL A 117ASP A 192TRP A 258PHE A 261PHE A 262ASN A 265TYR A 288 | NoneCAU A 500 ( 4.0A)CAU A 500 (-3.5A)CAU A 500 (-4.2A)NoneNoneCAU A 500 (-4.2A)CAU A 500 (-4.6A)CAU A 500 (-3.4A)CAU A 500 (-4.6A) | 0.71A | 6iblA-4gbrA:32.4 | 6iblA-4gbrA:50.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gi2 | CROTONYL-COACARBOXYLASE/REDUCTASE (Methylobacteriumextorquens) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | VAL A 321VAL A 303ASP A 264PHE A 289VAL A 259 | None | 1.48A | 6iblA-4gi2A:undetectable | 6iblA-4gi2A:21.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homo sapiens) |
PF00001(7tm_1)PF07361(Cytochrom_B562) | 7 | TRP A 131VAL A 136TRP A 337PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.8A)NoneERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.47A | 6iblA-4ib4A:28.0 | 6iblA-4ib4A:26.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ic5 | PROTEASE DO-LIKE 5,CHLOROPLASTIC (Arabidopsisthaliana) |
PF13365(Trypsin_2) | 5 | THR A 98VAL A 102VAL A 103ASP A 272ASN A 281 | None | 1.25A | 6iblA-4ic5A:undetectable | 6iblA-4ic5A:23.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iig | BETA-GLUCOSIDASE 1 (Aspergillusaculeatus) |
PF00933(Glyco_hydro_3)PF01915(Glyco_hydro_3_C)PF14310(Fn3-like) | 5 | THR A 187VAL A 185VAL A 184ASP A 280VAL A 74 | NoneNoneNoneBGC A 942 (-2.9A)None | 1.42A | 6iblA-4iigA:undetectable | 6iblA-4iigA:19.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lde | LYSOZYME, BETA-2ADRENERGIC RECEPTOR (Homo sapiens;Escherichiavirus T4) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 11 | TRP A1109THR A1110VAL A1114VAL A1117ASP A1192PHE A1193TRP A1286PHE A1289PHE A1290ASN A1293TYR A1316 | NoneP0G A1401 ( 3.9A)P0G A1401 (-3.7A)P0G A1401 ( 4.4A)NoneP0G A1401 (-3.8A)NoneP0G A1401 ( 4.7A)P0G A1401 ( 4.9A)P0G A1401 (-3.0A)None | 0.44A | 6iblA-4ldeA:41.0 | 6iblA-4ldeA:45.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mo2 | UDP-GALACTOPYRANOSEMUTASE (Campylobacterjejuni) |
no annotation | 5 | VAL B 352ASP B 198PHE B 197PHE B 58TYR B 68 | None | 1.43A | 6iblA-4mo2B:undetectable | 6iblA-4mo2B:19.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ni2 | GUANYLATE CYCLASESOLUBLE SUBUNITBETA-1 (Homo sapiens) |
PF00211(Guanylate_cyc) | 5 | VAL B 482VAL B 472ASP B 418VAL B 529TYR B 540 | NoneEDO B 701 ( 4.9A)NoneNoneNone | 1.48A | 6iblA-4ni2B:undetectable | 6iblA-4ni2B:16.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4om9 | SERINE PROTEASE PET (Escherichiacoli) |
PF02395(Peptidase_S6) | 5 | VAL A 864VAL A 895TRP A 933PHE A 906ASN A 873 | None | 1.45A | 6iblA-4om9A:undetectable | 6iblA-4om9A:17.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p37 | PUTATIVE POLY(A)POLYMERASE CATALYTICSUBUNIT (Megaviruschiliensis) |
no annotation | 5 | THR B 145VAL B 147VAL B 151PHE B 326PHE B 377 | None | 1.50A | 6iblA-4p37B:undetectable | 6iblA-4p37B:19.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qc8 | VP2 (Ungulatebocaparvovirus1) |
PF00740(Parvo_coat) | 5 | THR A 239VAL A 133VAL A 476PHE A 241PHE A 102 | None | 1.41A | 6iblA-4qc8A:undetectable | 6iblA-4qc8A:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tm3 | KTZI (Kutzneria sp.744) |
PF13434(K_oxygenase) | 5 | THR A 224VAL A 201VAL A 339ASP A 219PHE A 186 | None | 1.40A | 6iblA-4tm3A:2.2 | 6iblA-4tm3A:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tm3 | KTZI (Kutzneria sp.744) |
PF13434(K_oxygenase) | 5 | THR A 224VAL A 339ASP A 219TRP A 181PHE A 186 | None | 1.17A | 6iblA-4tm3A:2.2 | 6iblA-4tm3A:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u33 | ALPHA-1,4-GLUCAN:MALTOSE-1-PHOSPHATEMALTOSYLTRANSFERASE (Mycobacteriumtuberculosis) |
PF00128(Alpha-amylase)PF11896(DUF3416) | 5 | VAL A 273PHE A 414PHE A 498ASN A 496VAL A 417 | None | 1.50A | 6iblA-4u33A:undetectable | 6iblA-4u33A:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wk5 | GERANYLTRANSTRANSFERASE (Thermotoganeapolitana) |
PF00348(polyprenyl_synt) | 5 | THR A 44ASP A 260PHE A 261PHE A 193PHE A 197 | None | 1.49A | 6iblA-4wk5A:undetectable | 6iblA-4wk5A:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xmp | HEAVY CHAIN OFANTIBODY VRC08 (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 5 | THR H 83VAL H 111VAL H 109VAL H 67TYR H 90 | None | 1.29A | 6iblA-4xmpH:undetectable | 6iblA-4xmpH:18.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xs5 | SULFATETRANSPORTER/ANTISIGMA-FACTOR ANTAGONISTSTAS (Dyadobacterfermentans) |
PF01740(STAS) | 5 | THR A 80VAL A 46ASP A 87PHE A 85PHE A 21 | None | 1.48A | 6iblA-4xs5A:undetectable | 6iblA-4xs5A:16.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xz7 | PUTATIVEUNCHARACTERIZEDPROTEIN (Streptococcussuis) |
PF01841(Transglut_core) | 5 | THR A 266VAL A 262VAL A 259PHE A 313VAL A 303 | None | 1.45A | 6iblA-4xz7A:undetectable | 6iblA-4xz7A:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y1b | ANTE (Streptomycessp. NRRL 2288) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | VAL A 400ASP A 390PHE A 38PHE A 154VAL A 35 | None | 1.45A | 6iblA-4y1bA:undetectable | 6iblA-4y1bA:24.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z64 | PHYTOSULFOKINERECEPTOR 1 (Arabidopsisthaliana) |
PF00560(LRR_1)PF08263(LRRNT_2)PF13855(LRR_8) | 5 | VAL A 421VAL A 419PHE A 503PHE A 505VAL A 345 | None | 1.47A | 6iblA-4z64A:undetectable | 6iblA-4z64A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a4a | MATERNAL EFFECTPROTEIN OSKAR (Drosophilamelanogaster) |
PF17182(OSK) | 5 | VAL A 599VAL A 596TRP A 588ASN A 519VAL A 481 | None | 1.28A | 6iblA-5a4aA:undetectable | 6iblA-5a4aA:18.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5csl | ACETYL-COACARBOXYLASE (Saccharomycescerevisiae) |
PF00289(Biotin_carb_N)PF00364(Biotin_lipoyl)PF01039(Carboxyl_trans)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2)PF08326(ACC_central) | 5 | THR A 85VAL A 78ASP A 48PHE A 49VAL A 58 | None | 1.47A | 6iblA-5cslA:undetectable | 6iblA-5cslA:11.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5d1q | D2-06 HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 5 | THR B 83VAL B 111VAL B 109VAL B 67TYR B 90 | None | 1.36A | 6iblA-5d1qB:undetectable | 6iblA-5d1qB:19.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5d1z | D4-10 HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 5 | THR D 88VAL D 126VAL D 124VAL D 69TYR D 95 | None | 1.36A | 6iblA-5d1zD:undetectable | 6iblA-5d1zD:19.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f8u | BETA-1 ADRENERGICRECEPTOR (Meleagrisgallopavo) |
no annotation | 8 | TRP B 117THR B 118VAL B 122VAL B 125PHE B 201TRP B 303PHE B 307ASN B 310 | P32 B 400 (-4.8A)P32 B 400 (-3.8A)P32 B 400 (-3.5A)P32 B 400 ( 4.7A)P32 B 400 (-4.0A)NoneP32 B 400 (-4.9A)P32 B 400 (-3.5A) | 0.88A | 6iblA-5f8uB:34.2 | 6iblA-5f8uB:73.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f8u | BETA-1 ADRENERGICRECEPTOR (Meleagrisgallopavo) |
no annotation | 10 | TRP B 117THR B 118VAL B 122VAL B 125TRP B 303PHE B 306PHE B 307ASN B 310VAL B 326TYR B 333 | P32 B 400 (-4.8A)P32 B 400 (-3.8A)P32 B 400 (-3.5A)P32 B 400 ( 4.7A)NoneP32 B 400 (-4.1A)P32 B 400 (-4.9A)P32 B 400 (-3.5A)NoneP32 B 400 (-4.6A) | 0.66A | 6iblA-5f8uB:34.2 | 6iblA-5f8uB:73.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f8u | BETA-1 ADRENERGICRECEPTOR (Meleagrisgallopavo) |
no annotation | 5 | VAL B 122PHE B 306PHE B 307ASN B 310VAL B 326 | P32 B 400 (-3.5A)P32 B 400 (-4.1A)P32 B 400 (-4.9A)P32 B 400 (-3.5A)None | 1.33A | 6iblA-5f8uB:34.2 | 6iblA-5f8uB:73.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fbb | NUCLEASE S1 (Aspergillusoryzae) |
PF02265(S1-P1_nuclease) | 5 | TRP A 227THR A 223VAL A 221ASN A 115VAL A 133 | None | 1.47A | 6iblA-5fbbA:undetectable | 6iblA-5fbbA:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gmo | PROTEIN INDUCED BYOSMOTIC STRESS (Scheffersomycesstipitis) |
PF01370(Epimerase) | 5 | THR A 270VAL A 219ASP A 317PHE A 318VAL A 323 | None | 1.30A | 6iblA-5gmoA:undetectable | 6iblA-5gmoA:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5iaa | UBIQUITIN-LIKEMODIFIER-ACTIVATINGENZYME 5 (Homo sapiens) |
PF00899(ThiF) | 5 | VAL A 175VAL A 178PHE A 103PHE A 160VAL A 146 | None | 1.33A | 6iblA-5iaaA:undetectable | 6iblA-5iaaA:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ihr | PROBABLEBETA-GALACTOSIDASE A (Aspergillusniger) |
PF01301(Glyco_hydro_35)PF10435(BetaGal_dom2)PF13363(BetaGal_dom3)PF13364(BetaGal_dom4_5) | 5 | THR A 625VAL A 627VAL A 599PHE A 621ASN A 642 | DMS A3001 (-3.8A)NoneNoneNoneNone | 1.45A | 6iblA-5ihrA:undetectable | 6iblA-5ihrA:17.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5k2y | PROBABLE PERIPLASMICSUGAR-BINDINGLIPOPROTEIN USPC (Mycobacteriumtuberculosis) |
PF01547(SBP_bac_1) | 5 | VAL A 382VAL A 380ASP A 145TRP A 305PHE A 151 | None | 1.32A | 6iblA-5k2yA:undetectable | 6iblA-5k2yA:24.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ljy | SCFVA5 (Homo sapiens) |
PF07686(V-set) | 5 | THR H 83VAL H 111VAL H 109VAL H 67TYR H 90 | None | 1.44A | 6iblA-5ljyH:undetectable | 6iblA-5ljyH:18.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lu4 | PYRUVATE, PHOSPHATEDIKINASE,CHLOROPLASTIC (Flaveriatrinervia) |
PF00391(PEP-utilizers)PF01326(PPDK_N)PF02896(PEP-utilizers_C) | 5 | THR A 236VAL A 238VAL A 94ASP A 217ASN A 210 | None | 1.31A | 6iblA-5lu4A:undetectable | 6iblA-5lu4A:19.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mlq | CDPS (Nocardiabrasiliensis) |
no annotation | 5 | THR A 107VAL A 109VAL A 64ASP A 104TRP A 92 | None | 1.47A | 6iblA-5mlqA:undetectable | 6iblA-5mlqA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5oy0 | PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A2 (Synechocystissp. PCC 6803) |
no annotation | 5 | THR b 246ASP b 238TRP b 77PHE b 358TYR b 125 | None | 1.45A | 6iblA-5oy0b:2.5 | 6iblA-5oy0b:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v54 | 5-HYDROXYTRYPTAMINERECEPTOR 1B,OB-1FUSED 5-HT1BRECEPTOR,5-HYDROXYTRYPTAMINE RECEPTOR 1B (Spodopterafrugiperda;Homo sapiens) |
no annotation | 5 | TRP A 125TRP A 327PHE A 330PHE A 331TYR A 359 | None89F A1201 (-3.6A)89F A1201 (-4.1A)89F A1201 (-4.6A)None | 0.60A | 6iblA-5v54A:28.1 | 6iblA-5v54A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w8x | LIPID-A-DISACCHARIDESYNTHASE (Escherichiacoli) |
no annotation | 5 | VAL A 41ASP A 101PHE A 102PHE A 94PHE A 86 | None | 1.00A | 6iblA-5w8xA:undetectable | 6iblA-5w8xA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wde | KINESIN-LIKE PROTEINKIFC3 (Homo sapiens) |
PF00225(Kinesin) | 5 | VAL A 452VAL A 745ASP A 472PHE A 471ASN A 467 | NoneNoneUNX A 909 ( 3.7A)NoneNone | 1.45A | 6iblA-5wdeA:undetectable | 6iblA-5wdeA:20.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5wiv | D(4) DOPAMINERECEPTOR, SOLUBLECYTOCHROME B562CHIMERA (Escherichiacoli;Homo sapiens) |
no annotation | 5 | VAL A 116TRP A 407PHE A 410PHE A 411TYR A 438 | AQD A1201 ( 3.9A)NoneAQD A1201 (-4.7A)AQD A1201 (-4.6A)None | 0.53A | 6iblA-5wivA:26.9 | 6iblA-5wivA:30.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5wiv | D(4) DOPAMINERECEPTOR, SOLUBLECYTOCHROME B562CHIMERA (Escherichiacoli;Homo sapiens) |
no annotation | 5 | VAL A 116TRP A 407PHE A 410PHE A 411VAL A 430 | AQD A1201 ( 3.9A)NoneAQD A1201 (-4.7A)AQD A1201 (-4.6A)None | 1.26A | 6iblA-5wivA:26.9 | 6iblA-5wivA:30.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wqs | BETA-AMYLASE (Ipomoea batatas) |
no annotation | 5 | VAL A 53VAL A 55ASP A 32PHE A 77VAL A 29 | None | 1.48A | 6iblA-5wqsA:undetectable | 6iblA-5wqsA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yem | CATALASE (Mycothermusthermophilus) |
no annotation | 5 | VAL A 123VAL A 136ASP A 170PHE A 168PHE A 160 | NoneNoneNoneHEM A 704 (-3.6A)HEM A 704 (-3.7A) | 1.47A | 6iblA-5yemA:3.9 | 6iblA-5yemA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bqh | 5-HYDROXYTRYPTAMINERECEPTOR 2C,SOLUBLECYTOCHROME B562 (Escherichiacoli;Homo sapiens) |
no annotation | 6 | TRP A 130TRP A 324PHE A 327PHE A 328ASN A 331TYR A 358 | NoneE2J A1201 ( 3.7A)E2J A1201 (-4.6A)E2J A1201 (-4.4A)NoneNone | 0.56A | 6iblA-6bqhA:26.6 | 6iblA-6bqhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bqh | 5-HYDROXYTRYPTAMINERECEPTOR 2C,SOLUBLECYTOCHROME B562 (Escherichiacoli;Homo sapiens) |
no annotation | 6 | TRP A 130VAL A 135TRP A 324PHE A 327PHE A 328TYR A 358 | NoneE2J A1201 (-3.8A)E2J A1201 ( 3.7A)E2J A1201 (-4.6A)E2J A1201 (-4.4A)None | 0.63A | 6iblA-6bqhA:26.6 | 6iblA-6bqhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cm4 | D(2) DOPAMINERECEPTOR, ENDOLYSINCHIMERA (Homo sapiens;Escherichiavirus T4) |
no annotation | 5 | VAL A 115TRP A 386PHE A 389PHE A 390TYR A 416 | 8NU A2001 ( 3.5A)8NU A2001 ( 3.8A)8NU A2001 ( 4.5A)8NU A2001 ( 4.8A)8NU A2001 ( 4.9A) | 0.60A | 6iblA-6cm4A:26.6 | 6iblA-6cm4A:25.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cuf | - (-) |
no annotation | 5 | THR 5 83VAL 5 109VAL 5 107VAL 5 67TYR 5 90 | None | 1.46A | 6iblA-6cuf5:undetectable | 6iblA-6cuf5:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cuf | - (-) |
no annotation | 5 | THR 8 83VAL 8 111VAL 8 109VAL 8 67TYR 8 90 | None | 1.25A | 6iblA-6cuf8:undetectable | 6iblA-6cuf8:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6g79 | 5-HYDROXYTRYPTAMINERECEPTOR 1B (Homo sapiens) |
no annotation | 5 | TRP S 125TRP S 327PHE S 330PHE S 331TYR S 359 | NoneNoneEP5 S 401 (-4.0A)EP5 S 401 (-4.7A)EP5 S 401 ( 4.9A) | 0.51A | 6iblA-6g79S:23.9 | 6iblA-6g79S:undetectable |